Natamycin Eye Drops Manufacturer in India

Natamycin 5% ophthalmic suspension is the only topical antifungal medicine approved by regulatory agencies specifically for the treatment of fungal keratitis (fungal corneal ulcer). No other topical antifungal eye drop has the same level of clinical evidence and regulatory approval for this indication. Its polyene antifungal mechanism — binding to ergosterol in the fungal cell membrane — is distinct from azole antifungals and covers both Fusarium and Aspergillus species, the two most common causes of fungal keratitis.

Fungal keratitis is disproportionately prevalent in agricultural communities in tropical and subtropical regions — Africa, South Asia and Southeast Asia — where ocular injury from plant material, soil and agricultural dust is common. These are exactly the markets 9M India exports to. In many of these regions, fungal keratitis is a leading cause of monocular blindness and Natamycin 5% is the only available topical treatment. This creates consistent and critical demand.

Natamycin 5% ophthalmic suspension is active against Fusarium species (most common in tropical fungal keratitis), Aspergillus species (common in temperate climate fungal keratitis), Cephalosporium, Penicillium and many other filamentous fungi. Standard treatment regimen for fungal keratitis: one drop every 1–2 hours for the first few days, reducing to 6–8 times daily as the infection responds, continued for a minimum of 14–21 days.

Yes. Natamycin 5% is an ophthalmic suspension — not a solution — because Natamycin has very low water solubility. The bottle must be shaken well before each use to ensure uniform distribution of the suspended drug particles. Patients should be counselled on this point. Storage should be between 2–24°C, protected from light.

Yes. 9M India manufactures Natamycin 5% ophthalmic suspension for institutional and export supply. Given the critical nature of this formulation for fungal keratitis management in high-burden markets, we support government hospital ophthalmic departments, NGO procurement programmes and institutional buyers with large-volume supply backed by complete GMP documentation.

Documentation available includes WHO-GMP Certificate, DCGI Manufacturing Licence, Certificate of Pharmaceutical Product (CoPP), batch-wise Certificate of Analysis (sterility, particulate matter, pH, assay, resuspendability for suspension), ICH Zone IVb stability data and CTD/ACTD dossiers on request. Our regulatory team provides specific support for Natamycin registration as it is a specialty formulation with limited manufacturers globally.

Natamycin 5% is the first-line topical antifungal for fungal keratitis — particularly effective against Fusarium species. Voriconazole (available as an extemporaneously prepared eye drop in many centres) may be used for Aspergillus or Candida keratitis unresponsive to Natamycin. Most treatment guidelines recommend starting with Natamycin due to its established efficacy, regulatory approval and commercial availability as a prepared ophthalmic formulation.